Pulmonary Disease Doctors in Steubenville, OH Accepting Medicare

3 Pulmonary Disease doctors found. Showing 1 - 3

Stanley Joseph Matyasik, DO Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4100 Johnson Rd Ste 202, Steubenville, OH 43952 Phone: 740-314-8438    Fax: 740-672-3595

Edgar H Sanchez, MD Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 4100 Johnson Rd, Suite 208, Steubenville, OH 43952 Phone: 740-264-7800    Fax: 740-264-2334

Satyasagar Morisetty, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 401 Market St Ste 601, Steubenville, OH 43952 Phone: 740-314-5819    Fax: 740-792-4473

News Archive

Nab-Paclitaxel drug combo reduces risk of breast cancer recurrence

A recent large German study has shown that a new combination therapy for breast cancer treatment leads to a lowered risk of the disease coming back. A commentary on this landmark clinical trial has been published in the latest issue of the Journal of Clinical Oncology by the researchers Masey Ross and Charles Geyer Jr. from the VCU Massey Cancer Center. The commentary was titled, "Nab-Paclitaxel: A New Standard of Care in Neoadjuvant Therapy of High-Risk Early Breast Cancer?"

Vermillion, Kaiser Permanente partner to enhance diagnosis, treatment of ovarian cancer

Vermillion, Inc., a bio-analytical solutions company focused on gynecologic disease, today announced the initiation of a strategic partnership with Kaiser Permanente's Southern California Permanente Medical Group in order to enhance the diagnosis and treatment of ovarian cancer.

Study sheds light on novel functions of certain PCSK enzymes

Recent studies conducted at the Institut de recherches cliniques de Montr-al on a group of PCSK enzymes could have a positive impact on health, from cholesterol to osteoporosis.

FDA invites "Little Women" to present research on dangers of HPV vaccines

Called the "Little Women," six women who have spent the past three years listening, documenting and researching parental concerns about Gardasil have been invited to formally present their information to the FDA on March 12. FDA participants include the Office of Communication, Outreach and Development/Center of Biologics (CBER), Office of Biostatistics and Epidemiology, and Office of Vaccines Research and Review.

Read more Medical News

› Verified 6 days ago